|Articles|May 1, 2016

Eurofins BPT Adds 8 New Locations

To further its geographic reach and comprehensive service offerings, Eurofins BioPharma Product Testing (BPT) recently added eight state-of-the-art laboratory facilities to its global network of cGMP product testing labs through the acquisition of three leading bio/pharma service providers-Sinensis Life Sciences, ams Laboratories and Advantar Laboratories.

Click here to learn more about these recent acquisitions, as well as Eurofins BPT’s global capabilities and capacity.

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Eurofins BPT Adds 8 New Locations

Newsletter

Trending on BioPharm International

Regulatory Challenges for Global Manufacturing of Vaccines

EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation

AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D

Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025

Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis